9.44
price up icon3.51%   0.32
after-market 시간 외 거래: 8.97 -0.47 -4.98%
loading
전일 마감가:
$9.12
열려 있는:
$9
하루 거래량:
3.20M
Relative Volume:
0.53
시가총액:
$1.51B
수익:
$793.74M
순이익/손실:
$-398.71M
주가수익비율:
-1.3003
EPS:
-7.26
순현금흐름:
$-514.43M
1주 성능:
-6.26%
1개월 성능:
-30.64%
6개월 성능:
+91.48%
1년 성능:
+33.71%
1일 변동 폭
Value
$8.86
$9.48
1주일 범위
Value
$8.86
$10.07
52주 변동 폭
Value
$3.5324
$23.86

노바백스 Stock (NVAX) Company Profile

Name
명칭
Novavax Inc
Name
전화
240-268-2000
Name
주소
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Name
직원
1,992
Name
트위터
@novavax
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
NVAX's Discussions on Twitter

노바백스 Stock (NVAX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-08-09 업그레이드 B. Riley Securities Neutral → Buy
2023-04-20 다운그레이드 TD Cowen Outperform → Market Perform
2023-03-01 다운그레이드 B. Riley Securities Buy → Neutral
2023-01-09 재확인 B. Riley Securities Buy
2022-12-30 재확인 H.C. Wainwright Buy
2022-12-02 개시 Jefferies Hold
2022-09-22 다운그레이드 JP Morgan Neutral → Underweight
2022-05-20 개시 BofA Securities Underperform
2022-02-23 재확인 B. Riley Securities Buy
2022-02-22 재개 Jefferies Buy
2022-01-21 개시 Cowen Outperform
2021-05-12 다운그레이드 JP Morgan Overweight → Neutral
2020-12-14 개시 Jefferies Buy
2020-08-06 재확인 H.C. Wainwright Buy
2020-08-05 업그레이드 JP Morgan Neutral → Overweight
2020-08-05 다운그레이드 Ladenburg Thalmann Neutral → Sell
2020-07-16 재확인 H.C. Wainwright Buy
2020-07-08 다운그레이드 Ladenburg Thalmann Buy → Neutral
2020-06-29 재확인 B. Riley FBR Buy
2020-06-29 재확인 H.C. Wainwright Buy
2020-06-05 업그레이드 JP Morgan Underweight → Neutral
2020-05-28 재확인 B. Riley FBR Buy
2020-05-12 재확인 H.C. Wainwright Buy
2020-04-30 재확인 H.C. Wainwright Buy
2019-11-27 재개 B. Riley FBR Buy
2019-08-14 재확인 H.C. Wainwright Buy
2019-02-28 다운그레이드 Piper Jaffray Overweight → Underweight
2018-12-18 개시 Ladenburg Thalmann Buy
2018-12-11 개시 Oppenheimer Outperform
2018-11-26 업그레이드 Piper Jaffray Neutral → Overweight
2018-09-21 업그레이드 JP Morgan Underweight → Overweight
2018-03-29 업그레이드 Seaport Global Securities Neutral → Buy
모두보기

노바백스 주식(NVAX)의 최신 뉴스

pulisher
05:32 AM

Novavax Settles Vaccine Supply Agreement Dispute - TipRanks

05:32 AM
pulisher
05:22 AM

Novavax, UK terminate vaccine supply agreement - Reuters

05:22 AM
pulisher
03:16 AM

Novavax taps AstraZeneca, Pfizer alum to lead key manufacturing site - The Business Journals

03:16 AM
pulisher
12:01 PM

Dow Up Almost 300 Points as Voters Rush to Polls - Schaeffers Research

12:01 PM
pulisher
02:24 AM

Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 - The Malaysian Reserve

02:24 AM
pulisher
Nov 04, 2024

Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch

Nov 04, 2024
pulisher
Nov 04, 2024

Novavax appoints new General Manager for Swedish site in Uppsala - Marketscreener.com

Nov 04, 2024
pulisher
Nov 04, 2024

Åsa Manelius Named Managing Director of Novavax AB Site - PR Newswire

Nov 04, 2024
pulisher
Nov 04, 2024

Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

Novavax's vaccine was 96 percent effective in late-stage testing, as well as 86 percent effective against the British variant of COVID-19 - Telegrafi

Nov 03, 2024
pulisher
Nov 01, 2024

Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch

Nov 01, 2024
pulisher
Nov 01, 2024

Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Novavax, Inc.'s (NASDAQ:NVAX) 35% Dip In Price Shows Sentiment Is Matching Revenues - Simply Wall St

Nov 01, 2024
pulisher
Oct 31, 2024

Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? - Investor's Business Daily

Oct 31, 2024
pulisher
Oct 31, 2024

Novavax Q3 Earnings A Week AwayTime To Accept A New Reality (NASDAQ:NVAX) - Seeking Alpha

Oct 31, 2024
pulisher
Oct 30, 2024

Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Oct 30, 2024
pulisher
Oct 30, 2024

Noteworthy Wednesday Option Activity: NVAX, MRK, INOD - Nasdaq

Oct 30, 2024
pulisher
Oct 29, 2024

Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Oct 29, 2024
pulisher
Oct 29, 2024

Novavax (NVAX) Stock Dips While Market Gains: Key Facts - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Oct 29, 2024
pulisher
Oct 28, 2024

Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 28, 2024
pulisher
Oct 27, 2024

(NVAX) Trading Report - Stock Traders Daily

Oct 27, 2024
pulisher
Oct 27, 2024

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm - PR Newswire

Oct 27, 2024
pulisher
Oct 27, 2024

Bronstein, Gewirtz & Grossman, LLC Is Investigating Novavax, Inc. (NVAX) And Encourages Investors to Connect - AccessWire

Oct 27, 2024
pulisher
Oct 26, 2024

Novavax gets EU authorization for updated COVID-19 vaccine - MSN

Oct 26, 2024
pulisher
Oct 25, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc.NVAX - PR Newswire

Oct 25, 2024
pulisher
Oct 25, 2024

Novavax’s COVID-19 vaccine now available for all 194 WHO members - Maryland Daily Record

Oct 25, 2024
pulisher
Oct 25, 2024

Novavax’s updated COVID-19 vaccine receives positive opinion in EU - Maryland Daily Record

Oct 25, 2024
pulisher
Oct 25, 2024

Novavax: CDC approval for 2nd dose of Covid vaccine - Marketscreener.com

Oct 25, 2024
pulisher
Oct 24, 2024

Novavax Inc. stock outperforms competitors despite losses on the day - MarketWatch

Oct 24, 2024
pulisher
Oct 24, 2024

Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to Note - MSN

Oct 24, 2024
pulisher
Oct 23, 2024

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire

Oct 23, 2024
pulisher
Oct 23, 2024

Bronstein, Gewirtz & Grossman, LLC Encourages Novavax, Inc. (NVAX) Stockholders to Inquire about Securities Investigation - AccessWire

Oct 23, 2024
pulisher
Oct 21, 2024

Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - MSN

Oct 21, 2024
pulisher
Oct 21, 2024

This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip? - sharewise

Oct 21, 2024
pulisher
Oct 21, 2024

2024-10-21 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Novavax, Inc. (NVAX) And Encourages Investors to Reach Out | NDAQ:NVAX | Press Release - Stockhouse Publishing

Oct 21, 2024
pulisher
Oct 20, 2024

Novavax Stock Falls After FDA Puts Two Vaccine Programs on Hold - MSN

Oct 20, 2024
pulisher
Oct 20, 2024

How Bad Is This News for Novavax? - sharewise

Oct 20, 2024
pulisher
Oct 20, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Novavax, Inc. (NVAX) And Encourages Stockholders to Reach Out - AccessWire

Oct 20, 2024
pulisher
Oct 20, 2024

2024-10-20 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Novavax, Inc. (NVAX) And Encourages Stockholders to Reach Out | NDAQ:NVAX | Press Release - Stockhouse Publishing

Oct 20, 2024
pulisher
Oct 19, 2024

Novavax Plans to Cut Costs by Another $300 Million - MSN

Oct 19, 2024
pulisher
Oct 18, 2024

Novavax, Inc. (NASDAQ:NVAX) Stock Position Lifted by Vontobel Holding Ltd. - MarketBeat

Oct 18, 2024
pulisher
Oct 17, 2024

Novavax (NVAX) Advances While Market Declines: Some Information for Investors - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Novavax Stock Tumbles 20% After FDA Pauses Clinical Trial On Security Concerns - Barron's

Oct 17, 2024

노바백스 (NVAX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

노바백스 주식 (NVAX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Trizzino John
EVP, CCO and CBO
Aug 19 '24
Option Exercise
0.00
655
0
28,627
Kelly James Patrick
EVP, CFO and Treasurer
Aug 16 '24
Option Exercise
12.96
2,367
30,676
15,652
YOUNG JAMES F
Director
Jun 21 '24
Sale
14.09
7,500
105,675
61,760
YOUNG JAMES F
Director
Jun 18 '24
Sale
13.72
7,500
102,881
69,260
Dubovsky Filip
President, R&D
Jun 17 '24
Option Exercise
6.18
13,904
85,911
80,517
Dubovsky Filip
President, R&D
Jun 17 '24
Sale
14.47
13,904
201,164
66,613
MCGLYNN MARGARET G
Director
Jun 12 '24
Option Exercise
0.00
6,670
0
10,470
Alton Gregg H
Director
Jun 12 '24
Option Exercise
0.00
6,670
0
10,470
DOUGLAS RICHARD
Director
Jun 12 '24
Option Exercise
0.00
6,670
0
43,920
King Rachel K.
Director
Jun 12 '24
Option Exercise
0.00
6,670
0
18,920
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):